呼吸指南

订阅

MedSci主页 / 所有栏目 / 呼吸指南

2018 GOLD慢性阻塞性肺疾病全球倡议：COPD诊断、治疗与预防全球策略

2017-11-01 慢性阻塞性肺疾病全球倡议 GOLD官网

慢性阻塞性肺病COPD

慢性阻塞性肺疾病全球倡议组织最新发布了2018版GOLD慢阻肺诊断治疗和预防的全球策略报告，文章主要是对2017版的的修改。

中文标题：

2018 GOLD慢性阻塞性肺疾病全球倡议：COPD诊断、治疗与预防全球策略

英文标题：

GLOBAL STRATEGY FOR THE DIAGNOSIS, MANAGEMENT, AND PREVENTION OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE ：2018 REPORT

发布机构：

慢性阻塞性肺疾病全球倡议

发布日期：

2017-11-01

简要介绍：

慢性阻塞性肺疾病全球倡议组织最新发布了2018版GOLD慢阻肺诊断治疗和预防的全球策略报告，文章主要是对2017版的的修改。

 

拓展指南：与慢性阻塞性肺病相关指南：

相关资料下载：
[AttachmentFileName(sort=100, fileName=2018 GOLD慢性阻塞性肺疾病全球倡议：COPD诊断、治疗与预防全球策略)] GetToolGuiderByIdResponse(projectId=1, id=558721c0015201c6, title=2018 GOLD慢性阻塞性肺疾病全球倡议：COPD诊断、治疗与预防全球策略, enTitle=GLOBAL STRATEGY FOR THE DIAGNOSIS, MANAGEMENT, AND PREVENTION OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE ：2018 REPORT, guiderFrom=GOLD官网, authorId=null, author=, summary=慢性阻塞性肺疾病全球倡议组织最新发布了2018版GOLD慢阻肺诊断治疗和预防的全球策略报告，文章主要是对2017版的的修改。 , cover=, journalId=null, articlesId=null, associationId=202, associationName=慢性阻塞性肺疾病全球倡议, associationIntro=null, copyright=0, guiderPublishedTime=Wed Nov 01 00:00:00 CST 2017, originalUrl=, linkOutUrl=, content=<P>慢性阻塞性肺疾病全球倡议组织最新发布了2018版GOLD慢阻肺诊断治疗和预防的全球策略报告，文章主要是对2017版的的修改。 </P> <P> </P>拓展指南：<strong>与<font color=red>慢性阻塞性肺病</font>相关指南：</strong><br><ul><li><a href="http://www.medsci.cn/guideline/show_article.do?id=e111f1c001ae560b" title="2017 BC指南：慢性阻塞性肺病的诊断和管理" target=_blank>2017 BC指南：慢性阻塞性肺病的诊断和管理</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=252cc1c001160a88" title="慢性阻塞性肺病全球倡议慢性阻塞性肺病 指南（2013更新版）解读" target=_blank>慢性阻塞性肺病全球倡议慢性阻塞性肺病 指南（2013更新版）解读</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=7b7dc1c00080e708" title="2011SATS 慢性阻塞性肺病诊治指南" target=_blank>2011SATS 慢性阻塞性肺病诊治指南</a></li> 更多信息请点击：<a href="http://www.medsci.cn/guideline/list.do?q=%E6%85%A2%E6%80%A7%E9%98%BB%E5%A1%9E%E6%80%A7%E8%82%BA%E7%97%85" target=_blank>有关慢性阻塞性肺病更多指南</a></ul>, tagList=[TagDto(tagId=7070, tagName=慢性阻塞性肺病), TagDto(tagId=295, tagName=COPD)], categoryList=[CategoryDto(categoryId=12, categoryName=呼吸, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=其他, guiderLanguage=0, guiderRegion=4, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=14805, appHits=2007, showAppHits=12, pcHits=10228, showPcHits=3667, likes=168, shares=56, comments=16, approvalStatus=1, publishedTime=Thu Nov 16 21:40:13 CST 2017, publishedTimeString=2017-11-01, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Thu Nov 16 21:40:13 CST 2017, updatedBy=null, updatedName=null, updatedTime=Sat Jan 06 15:31:36 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=2018 GOLD慢性阻塞性肺疾病全球倡议：COPD诊断、治疗与预防全球策略)])
2018 GOLD慢性阻塞性肺疾病全球倡议：COPD诊断、治疗与预防全球策略
下载请点击：
评论区 (13)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2210293, encodeId=75b3221029363, content=有中文版的吗, beContent=null, objectType=guider, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8bf09296116, createdName=ms3000002013465700, createdTime=Mon Jun 17 12:14:05 CST 2024, time=2024-06-17, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2151409, encodeId=327021514097b, content=要中文版, beContent=null, objectType=guider, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ff775567443, createdName=ms1000002007247386, createdTime=Sat Aug 05 19:22:48 CST 2023, time=2023-08-05, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1234108, encodeId=b920123410830, content=想要中文版的, beContent=null, objectType=guider, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2de98247297, createdName=ms1000001345026916, createdTime=Fri Jul 22 23:43:56 CST 2022, time=2022-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1211908, encodeId=b75d121190848, content=有中文版的吗？, beContent=null, objectType=guider, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211217/2b5685b164a643778fec5f62a3898899/4924957781864362be18417e08b257a1.jpg, createdBy=66fd6410070, createdName=葡萄麻麻, createdTime=Sun Apr 17 14:44:29 CST 2022, time=2022-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=907910, encodeId=d9ad90e91095, content=学习最新进展, beContent=null, objectType=guider, channel=null, level=null, likeNumber=212, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201214/b3170121d995432ea306ae3a7809cc05/2cfb236f361b4d3c80ef8fdef4301832.jpg, createdBy=8ad35400531, createdName=MMCyuan, createdTime=Mon Dec 14 18:40:23 CST 2020, time=2020-12-14, status=1, ipAttribution=)]
    2024-06-17 ms3000002013465700 来自江苏省

    有中文版的吗

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2210293, encodeId=75b3221029363, content=有中文版的吗, beContent=null, objectType=guider, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8bf09296116, createdName=ms3000002013465700, createdTime=Mon Jun 17 12:14:05 CST 2024, time=2024-06-17, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2151409, encodeId=327021514097b, content=要中文版, beContent=null, objectType=guider, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ff775567443, createdName=ms1000002007247386, createdTime=Sat Aug 05 19:22:48 CST 2023, time=2023-08-05, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1234108, encodeId=b920123410830, content=想要中文版的, beContent=null, objectType=guider, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2de98247297, createdName=ms1000001345026916, createdTime=Fri Jul 22 23:43:56 CST 2022, time=2022-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1211908, encodeId=b75d121190848, content=有中文版的吗？, beContent=null, objectType=guider, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211217/2b5685b164a643778fec5f62a3898899/4924957781864362be18417e08b257a1.jpg, createdBy=66fd6410070, createdName=葡萄麻麻, createdTime=Sun Apr 17 14:44:29 CST 2022, time=2022-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=907910, encodeId=d9ad90e91095, content=学习最新进展, beContent=null, objectType=guider, channel=null, level=null, likeNumber=212, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201214/b3170121d995432ea306ae3a7809cc05/2cfb236f361b4d3c80ef8fdef4301832.jpg, createdBy=8ad35400531, createdName=MMCyuan, createdTime=Mon Dec 14 18:40:23 CST 2020, time=2020-12-14, status=1, ipAttribution=)]
    2023-08-05 ms1000002007247386 来自广东省

    要中文版

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=2210293, encodeId=75b3221029363, content=有中文版的吗, beContent=null, objectType=guider, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8bf09296116, createdName=ms3000002013465700, createdTime=Mon Jun 17 12:14:05 CST 2024, time=2024-06-17, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2151409, encodeId=327021514097b, content=要中文版, beContent=null, objectType=guider, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ff775567443, createdName=ms1000002007247386, createdTime=Sat Aug 05 19:22:48 CST 2023, time=2023-08-05, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1234108, encodeId=b920123410830, content=想要中文版的, beContent=null, objectType=guider, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2de98247297, createdName=ms1000001345026916, createdTime=Fri Jul 22 23:43:56 CST 2022, time=2022-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1211908, encodeId=b75d121190848, content=有中文版的吗？, beContent=null, objectType=guider, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211217/2b5685b164a643778fec5f62a3898899/4924957781864362be18417e08b257a1.jpg, createdBy=66fd6410070, createdName=葡萄麻麻, createdTime=Sun Apr 17 14:44:29 CST 2022, time=2022-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=907910, encodeId=d9ad90e91095, content=学习最新进展, beContent=null, objectType=guider, channel=null, level=null, likeNumber=212, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201214/b3170121d995432ea306ae3a7809cc05/2cfb236f361b4d3c80ef8fdef4301832.jpg, createdBy=8ad35400531, createdName=MMCyuan, createdTime=Mon Dec 14 18:40:23 CST 2020, time=2020-12-14, status=1, ipAttribution=)]
    2022-07-22 ms1000001345026916

    想要中文版的

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2210293, encodeId=75b3221029363, content=有中文版的吗, beContent=null, objectType=guider, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8bf09296116, createdName=ms3000002013465700, createdTime=Mon Jun 17 12:14:05 CST 2024, time=2024-06-17, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2151409, encodeId=327021514097b, content=要中文版, beContent=null, objectType=guider, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ff775567443, createdName=ms1000002007247386, createdTime=Sat Aug 05 19:22:48 CST 2023, time=2023-08-05, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1234108, encodeId=b920123410830, content=想要中文版的, beContent=null, objectType=guider, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2de98247297, createdName=ms1000001345026916, createdTime=Fri Jul 22 23:43:56 CST 2022, time=2022-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1211908, encodeId=b75d121190848, content=有中文版的吗？, beContent=null, objectType=guider, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211217/2b5685b164a643778fec5f62a3898899/4924957781864362be18417e08b257a1.jpg, createdBy=66fd6410070, createdName=葡萄麻麻, createdTime=Sun Apr 17 14:44:29 CST 2022, time=2022-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=907910, encodeId=d9ad90e91095, content=学习最新进展, beContent=null, objectType=guider, channel=null, level=null, likeNumber=212, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201214/b3170121d995432ea306ae3a7809cc05/2cfb236f361b4d3c80ef8fdef4301832.jpg, createdBy=8ad35400531, createdName=MMCyuan, createdTime=Mon Dec 14 18:40:23 CST 2020, time=2020-12-14, status=1, ipAttribution=)]
    2022-04-17 葡萄麻麻

    有中文版的吗？

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=2210293, encodeId=75b3221029363, content=有中文版的吗, beContent=null, objectType=guider, channel=null, level=null, likeNumber=122, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8bf09296116, createdName=ms3000002013465700, createdTime=Mon Jun 17 12:14:05 CST 2024, time=2024-06-17, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2151409, encodeId=327021514097b, content=要中文版, beContent=null, objectType=guider, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ff775567443, createdName=ms1000002007247386, createdTime=Sat Aug 05 19:22:48 CST 2023, time=2023-08-05, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1234108, encodeId=b920123410830, content=想要中文版的, beContent=null, objectType=guider, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2de98247297, createdName=ms1000001345026916, createdTime=Fri Jul 22 23:43:56 CST 2022, time=2022-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1211908, encodeId=b75d121190848, content=有中文版的吗？, beContent=null, objectType=guider, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211217/2b5685b164a643778fec5f62a3898899/4924957781864362be18417e08b257a1.jpg, createdBy=66fd6410070, createdName=葡萄麻麻, createdTime=Sun Apr 17 14:44:29 CST 2022, time=2022-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=907910, encodeId=d9ad90e91095, content=学习最新进展, beContent=null, objectType=guider, channel=null, level=null, likeNumber=212, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201214/b3170121d995432ea306ae3a7809cc05/2cfb236f361b4d3c80ef8fdef4301832.jpg, createdBy=8ad35400531, createdName=MMCyuan, createdTime=Mon Dec 14 18:40:23 CST 2020, time=2020-12-14, status=1, ipAttribution=)]
    2020-12-14 MMCyuan

    学习最新进展

    0

以上为热门评论，梅斯医学App还有更多内容

相关指南

2017 GOLD慢性阻塞性肺疾病全球倡议：COPD诊断、治疗与预防全球策略

暂未更新 · 2016-11-10

慢性阻塞性肺病全球倡议慢性阻塞性肺病 指南（2013更新版）解读

暂未更新 · 2016-04-20